abstract |
A combined preparation comprising an A 2A adenosine receptor agonist and a calcium channel blocker is described. The effect of the A 2A adenosine receptor agonist is enhanced in the presence of the calcium channel blocker. Methods for treatment of pathological conditions using the combined preparation are described. |